Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Prostatic Neoplasms 3Pain, Postoperative 3Neoplasms 3Lung Neoplasms 3Breast Neoplasms 3Pancreatic Neoplasms 2Pain 2Colonic Neoplasms 2Choledocholithiasis 2Choledochal Cyst 2Anxiety Disorders 2Urinary Bladder Neoplasms 1Terminal Cancer 1Stomach Neoplasms 1Solid Tumor 1Skin Neoplasms 1Sedation 1Rectal Neoplasms 1Postoperative Cognitive Complications 1Polyps 1Personal Satisfaction 1Patient Satisfaction 1Parasomnias 1Pancreatitis 1Pain, Intractable 1Opioid-Related Disorders 1Nausea 1Mouth Neoplasms 1Healthy 1Glioma 1

Interventions

Dexmedetomidine 5Saline Solution 4Haloperidol 4Sodium Chloride 3Surveys and Questionnaires 2Propofol 2Lorazepam 2suvorexant 1remimazolam 1haloperidol decanoate 1flurbiprofen axetil 1dexamethasone 21-phosphate 1Vitamin E 1Standard of Care 1Sevoflurane 1Practice Guidelines as Topic 1Pemetrexed 1Paclitaxel 1Olanzapine 1Neoadjuvant Therapy 1Midazolam 1Mental Status and Dementia Tests 1Melatonin 1Interviews as Topic 1Injections 1Inhalation 1Ibuprofen 1Donepezil 1Dexamethasone 1Chlorpromazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Delirium × Midazolam × Clear all
NCT01687751 2015-05-25

Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

Fraser Health

Phase 2 Withdrawn
Other

Death, Delirium, Dyspnea, Nausea, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡